These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 27550357)

  • 1. Dual Targeting of Cell Wall Precursors by Teixobactin Leads to Cell Lysis.
    Homma T; Nuxoll A; Gandt AB; Ebner P; Engels I; Schneider T; Götz F; Lewis K; Conlon BP
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6510-6517. PubMed ID: 27550357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the
    G C B; Sahukhal GS; Elasri MO
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307991
    [No Abstract]   [Full Text] [Related]  

  • 3. Hidden Mode of Action of Glycopeptide Antibiotics: Inhibition of Wall Teichoic Acid Biosynthesis.
    Singh M; Chang J; Coffman L; Kim SJ
    J Phys Chem B; 2017 Apr; 121(16):3925-3932. PubMed ID: 28368603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of β-Glycosylated Wall Teichoic Acids in the Reduction of Vancomycin Susceptibility in Vancomycin-Intermediate Staphylococcus aureus.
    Hort M; Bertsche U; Nozinovic S; Dietrich A; Schrötter AS; Mildenberger L; Axtmann K; Berscheid A; Bierbaum G
    Microbiol Spectr; 2021 Oct; 9(2):e0052821. PubMed ID: 34668723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of the role of cell wall homeostasis in
    Salamaga B; Kong L; Pasquina-Lemonche L; Lafage L; von Und Zur Muhlen M; Gibson JF; Grybchuk D; Tooke AK; Panchal V; Culp EJ; Tatham E; O'Kane ME; Catley TE; Renshaw SA; Wright GD; Plevka P; Bullough PA; Han A; Hobbs JK; Foster SJ
    Proc Natl Acad Sci U S A; 2021 Nov; 118(44):. PubMed ID: 34716264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Teixobactin, the first of a new class of antibiotics discovered by iChip technology?
    Piddock LJ
    J Antimicrob Chemother; 2015 Oct; 70(10):2679-80. PubMed ID: 26089440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus.
    Katayama Y; Sekine M; Hishinuma T; Aiba Y; Hiramatsu K
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3730-42. PubMed ID: 27067329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus.
    Sieradzki K; Tomasz A
    J Bacteriol; 2003 Dec; 185(24):7103-10. PubMed ID: 14645269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new antibiotic kills pathogens without detectable resistance.
    Ling LL; Schneider T; Peoples AJ; Spoering AL; Engels I; Conlon BP; Mueller A; Schäberle TF; Hughes DE; Epstein S; Jones M; Lazarides L; Steadman VA; Cohen DR; Felix CR; Fetterman KA; Millett WP; Nitti AG; Zullo AM; Chen C; Lewis K
    Nature; 2015 Jan; 517(7535):455-9. PubMed ID: 25561178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus.
    Cui L; Iwamoto A; Lian JQ; Neoh HM; Maruyama T; Horikawa Y; Hiramatsu K
    Antimicrob Agents Chemother; 2006 Feb; 50(2):428-38. PubMed ID: 16436693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics Study.
    Hussein M; Karas JA; Schneider-Futschik EK; Chen F; Swarbrick J; Paulin OKA; Hoyer D; Baker M; Zhu Y; Li J; Velkov T
    mSystems; 2020 May; 5(3):. PubMed ID: 32457238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Katanosin B and plusbacin A(3), inhibitors of peptidoglycan synthesis in methicillin-resistant Staphylococcus aureus.
    Maki H; Miura K; Yamano Y
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1823-7. PubMed ID: 11353632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative proteomic analysis of Staphylococcus aureus strains with differences in resistance to the cell wall-targeting antibiotic vancomycin.
    Pieper R; Gatlin-Bunai CL; Mongodin EF; Parmar PP; Huang ST; Clark DJ; Fleischmann RD; Gill SR; Peterson SN
    Proteomics; 2006 Aug; 6(15):4246-58. PubMed ID: 16826566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational Design and Synthesis of Modified Teixobactin Analogues: In Vitro Antibacterial Activity against Staphylococcus aureus, Propionibacterium acnes and Pseudomonas aeruginosa.
    Ng V; Kuehne SA; Chan WC
    Chemistry; 2018 Jun; 24(36):9136-9147. PubMed ID: 29741277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A defect in cell wall recycling confers antibiotic resistance and sensitivity in Staphylococcus aureus.
    Tan S; Cho K; Nodwell JR
    J Biol Chem; 2022 Oct; 298(10):102473. PubMed ID: 36089064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the Binding Interactions of Teixobactin with the Bacterial Cell-Wall Precursor Lipid II.
    Chiorean S; Antwi I; Carney DW; Kotsogianni I; Giltrap AM; Alexander FM; Cochrane SA; Payne RJ; Martin NI; Henninot A; Vederas JC
    Chembiochem; 2020 Mar; 21(6):789-792. PubMed ID: 31552694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of novel teixobactin analogues.
    Schumacher CE; Harris PWR; Ding XB; Krause B; Wright TH; Cook GM; Furkert DP; Brimble MA
    Org Biomol Chem; 2017 Oct; 15(41):8755-8760. PubMed ID: 28993827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of potent wall teichoic acid early stage inhibitors.
    Labroli MA; Caldwell JP; Yang C; Lee SH; Wang H; Koseoglu S; Mann P; Yang SW; Xiao J; Garlisi CG; Tan C; Roemer T; Su J
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3999-4002. PubMed ID: 27436582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autolysis control hypotheses for tolerance to wall antibiotics.
    Koch AL
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2671-5. PubMed ID: 11557453
    [No Abstract]   [Full Text] [Related]  

  • 20. [Influence of Polycations on Antibacterial Activity of Lysostaphin].
    Kulikov SN; Khairullin RZ; Varlamov VP
    Prikl Biokhim Mikrobiol; 2015; 51(6):610-5. PubMed ID: 26859963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.